InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: BCS Paladin post# 198614

Friday, 12/05/2014 12:01:34 PM

Friday, December 05, 2014 12:01:34 PM

Post# of 345969
I can picture Art Levinson now and his first couple conversations with Google Execs in how the talks "could" have gone.

AL: Mr Google or shall I call you Mr. Calico

CALICO: Lets skip to the chase Art. We think you are our man if you want the job

AL: Promise me that Roche will not be walking through the front or back door trying to buy you out.

CALICO: (smirking and laughter under the breath) ... Art, we could easily buy Roche out if we wanted... but maybe we will wait 10 years when they will be cheaper to pick up. Now, lets get to the hot topic.... tell us more about these guys you worked with at Genentech... lets start with Robert Garnick...

...

BCS, my #1 CALICO choice with no Big Pharma type pipeline baggage that would delay Bavi expansion is a big reason to go all in for Peregrine. Will the price stay low so I can put more into a ROTH account for 2015? I doubt it will stay this low

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News